Impairment of Calcium-Activated Potassium Channels in Endothelium-Derived Hyperpolarizing Factor Responses in Spontaneously Hypertensive Rats
- フォーマット:
- 論文
- 責任表示:
- Hasegawa, Kazushi ; Oikawa, Koichi ; Yoshida, Ikko ; Ishizaka, Hiroshi ; Osanai, Tomohiro ; Motomura, Shigeru ; Okumura, Ken
- 言語:
- 英語
- 出版情報:
- 弘前大学大学院医学研究科・弘前医学会, 2009-03-31
- 著者名:
Hasegawa, Kazushi Oikawa, Koichi Yoshida, Ikko Ishizaka, Hiroshi Osanai, Tomohiro Motomura, Shigeru Okumura, Ken - 掲載情報:
- 弘前医学
- ISSN:
- 0439-1721
- 巻:
- 60
- 通号:
- 1/2/3/4
- 開始ページ:
- 86
- 終了ページ:
- 95
- バージョン:
- publisher
- 概要:
- To examine the effect of chronic hypertension on endothelium-derived hyperpolarizing factor( EDHF)responses, the hearts of Wistar-Kyoto rats( WKY) and spontaneously hypertensive rats( SHR) were isolated andperfused using Langendorff system … with constant perfusion pressure. Bradykinin increased coronary fl ow( CF) dosedependentlyand this was not aff ected by NG-nitro-L-arginine methyl ester or indomethacin, indicating that bradykinin’seff ect on CF was not mediated by nitric oxide or prostacyclin but by EDHF. Bradykinin-induced CF increase was smallerin SHR than in WKY. Tetrabutylammonium( a non-specific KCa channel blocker) abolished bradykinin-induced CFincrease in both rats. 1-Ethyl-2-benzimedazolinone( 1-EBIO, an agonist of intermediate conductance KCa channel)-inducedincrease in CF was smaller in SHR than in WKY. 1,3-Dihydro-1-[2-hydroxy-5(- trifl uoromethyl) phenyl]-5(- trifl uoromethyl)-2H-benzimidazol-2-one( NS1619, an agonist of large conductance KCa channel)-induced increase in CF did not differbetween SHR and WKY. In early stage of hypertension, there was no signifi cant diff erence between SHR and WKY inbradykinin- and 1-EBIO-induced increases in CF. In conclusion, EDHF response in coronary microcirculation is impairedin SHR due to dysfunction of intermediate-conductance calcium-activated potassium channels. 続きを見る
- URL:
- http://hdl.handle.net/10129/1801
類似資料:
7
論文
Role of Protein Kinase C in Acetylcholine-Induced Ca2+ Influx under Enhanced Phospholipase C-δ1
弘前大学大学院医学研究科・弘前医学会 | |
弘前大学大学院医学研究科・弘前医学会 | |
弘前大学大学院医学研究科・弘前医学会 | |
弘前大学大学院医学研究科・弘前医学会 |